The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients. (Record no. 21075470)

MARC details
000 -LEADER
fixed length control field 02231 a2200685 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516051707.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201111s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-8042
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2217/pgs.11.54
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name van Schaik, Ron H N
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20111102
245 00 - TITLE STATEMENT
Title The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmacogenomics
Date of publication, distribution, etc. Aug 2011
300 ## - PHYSICAL DESCRIPTION
Extent 1137-46 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Hormonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aryl Hydrocarbon Hydroxylases
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytochrome P-450 CYP2C19
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytochrome P-450 CYP2D6
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element DNA, Neoplasm
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Data Interpretation, Statistical
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphatic Metastasis
General subdivision pathology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Menopause
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacogenetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Predictive Value of Tests
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Progesterone
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tamoxifen
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kok, Marleen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sweep, Fred C G J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Vliet, Martin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Fessem, Marianne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meijer-van Gelder, Marion E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Seynaeve, Caroline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lindemans, Jan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wesseling, Jelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Van 't Veer, Laura J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Span, Paul N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Laarhoven, Hanneke
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sleijfer, Stefan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Foekens, John A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Linn, Sabine C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berns, Els M J J
773 0# - HOST ITEM ENTRY
Title Pharmacogenomics
Related parts vol. 12
-- no. 8
-- p. 1137-46
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2217/pgs.11.54">https://doi.org/10.2217/pgs.11.54</a>
Public note Available from publisher's website

No items available.